A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD

- Singanayagam, Aran, Glanville, Nicholas, Walton, Ross P., Aniscenko, Julia, Pearson, Rebecca M., Pinkerton, James W., Horvat, Jay C., Hansbro, Philip M., Bartlett, Nathan W., Johnston, Sebastian L.

Inflammasomes in COPD and neutrophilic asthma

- Kim, Richard Y., Pinkerton, James W., Gibson, Peter G., Cooper, Matthew A., Horvat, Jay C., Hansbro, Philip M.

Inflammasomes in the lung

- Pinkerton, James W., Kim, Richard Y., Robertson, Avril A. B., Hirota, Jeremy A., Wood, Lisa G., Knight, Darryl A., Cooper, Matthew A., O'Neill, Luke A. J., Horvat, Jay C., Hansbro, Philip M.

Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma

- Essilfie, Ama-Tawiah, Horvat, Jay C., Hansbro, Philip M., Kim, Richard Y., Mayall, Jemma R., Pinkerton, James W., Beckett, Emma L., Starkey, Malcolm R., Simpson, Jodie L., Foster, Paul S., Gibson, Peter G.

MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2

- Kim, Richard Y., Horvat, Jay C., Sunkara, Krishna P., Nguyen, Thi Hiep, Jarnicki, Andrew G., Keely, Simon, Mattes, Joerg, Adcock, Ian M., Foster, Paul S., Hansbro, Philip M., Pinkerton, James W., Starkey, Malcolm R., Essilfie, Ama T., Mayall, Jemma R., Nair, Prema M., Hansbro, Nicole G., Jones, Bernadette, Haw, Tatt Jhong

Role for NLRP3 inflammasome-mediated, IL-1ß-dependent responses in severe, steroid-resistant asthma

- Kim, Richard Y., Pinkerton, James W., Hirota, Jeremy A., Wood, Lisa G., Simpson, Jodie L., Knight, Darryl A., Wark, Peter A., Gibson, Peter G., O'Neill, Luke A. J., Cooper, Matthew A., Horvat, Jay C., Hansbro, Philip M., Essilfie, Ama T., Robertson, Avril A. B., Baines, Katherine J., Brown, Alexandra C., Mayall, Jemma R., Ali, M. Khadem, Starkey, Malcolm R., Hansbro, Nicole G.